| Long-term effects of nonselective endothelin A and B receptor antagonism in postinfarction rat: importance of timing. | |
| | |
MedLine Citation:
|
PMID: 11673349 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Some controversy exists as to the effects of endothelin (ET) receptor antagonism on long-term post-myocardial infarction (MI) evolution, particularly as it relates to the timing of the intervention after MI (<24 hours versus 10 days). METHODS AND RESULTS: Sham rats and rats surviving an acute MI for >20 hours (n=301) were assigned to treatment with saline or the nonselective ET(A) and ET(B) receptor antagonist LU 420627 (LU) started <24 hours (early) or 10 days (late) after MI and continued for 100 days. Long-term LU treatment led to increased mortality of rats with large MI, regardless of the timing of initiation of therapy. Early initiation of LU reduced survival from 61% to 16% (P<0.001 versus untreated), and later initiation reduced survival to 36% (P=0.012 versus untreated and P<0.001 versus early initiation). Early initiation of LU led to scar thinning, further left ventricular (LV) dilatation, LV dysfunction, and an excessive rise in right ventricular systolic pressure. Later initiation of LU did not modify scar formation but resulted in LV dilatation and dysfunction compared with the untreated group. Cardiac fibrosis tended to increase in the LU-treated MI groups. LU in the sham group reduced cardiac endothelial constitutive nitric oxide synthase but did not modify the changes that occurred with a large MI. CONCLUSIONS: The use of the nonselective ET(A) and ET(B) receptor antagonist LU results in reduced survival, ventricular dilatation, and dysfunction whether started early or late after MI. Early initiation of LU resulted in scar expansion and a particularly unfavorable outcome. |
| | |
Authors:
|
Q T Nguyen; P Cernacek; M G Sirois; A Calderone; N Lapointe; D J Stewart; J L Rouleau |
Related Documents
:
|
18091409 - Percutaneous coronary intervention in the elderly for myocardial infarction in the post... 17095869 - The relationship between transmural extent of infarction on contrast enhanced magnetic ... 20118149 - Adjunctive thrombectomy for acute myocardial infarction: a bayesian meta-analysis. 17846319 - Early repair of moderate ischemic mitral regurgitation reverses left ventricular remode... 12109639 - Gusto v: combination drug treatment of acute myocardial infarction. global use of strat... 16569539 - Ventricular arrhythmias after acute myocardial infarction: a 20-year community study. 6720519 - High prevalence of nonsustained ventricular tachycardia in severe congestive heart fail... 17703159 - Evaluation of stentangioplasty in university cardiac center. 3154679 - Role of calcium channel blockers in experimental exercise-induced ischemia. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Circulation Volume: 104 ISSN: 1524-4539 ISO Abbreviation: Circulation Publication Date: 2001 Oct |
Date Detail:
|
Created Date: 2001-10-23 Completed Date: 2001-12-04 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0147763 Medline TA: Circulation Country: United States |
Other Details:
|
Languages: eng Pagination: 2075-81 Citation Subset: AIM; IM |
Affiliation:
|
Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Dilatation, Pathologic / chemically induced, physiopathology Disease Models, Animal Drug Administration Schedule Endothelins / pharmacology Ligands Male Myocardial Infarction / drug therapy, physiopathology* Peptide Fragments / pharmacology Rats Rats, Wistar Receptor, Endothelin A Receptor, Endothelin B Receptors, Endothelin / agonists, antagonists & inhibitors* Survival Rate Time Ventricular Dysfunction / chemically induced, physiopathology |
| Chemical | |
Reg. No./Substance:
|
0/Endothelins; 0/Ligands; 0/Peptide Fragments; 0/Receptor, Endothelin A; 0/Receptor, Endothelin B; 0/Receptors, Endothelin; 143113-45-5/BQ 3020 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a be...
Next Document: Spatial heterogeneity of calcium transient alternans during the early phase of myocardial ischemia i...